TradeOrgs
  • 🇮🇳 India
  • 🇺🇸 US
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,218.00▼ 7.87%TCS₹2,100.00▼ 8.85%HDFCBANK₹711.45▼ 0.09%ICICIBANK₹1,342.80▼ 5.65%INFY₹1,013.85▼ 10.28%HINDUNILVR₹1,895.20▼ 3.96%ITC₹266.70▲ 0.98%SBIN₹958.75▼ 5.64%BHARTIARTL₹1,810.50▼ 1.60%KOTAKBANK₹431.90▲ 1.74%LT₹3,770.00▼ 4.90%AXISBANK₹1,248.00▼ 1.96%ASIANPAINT₹2,424.20▼ 4.08%MARUTI₹11,625.00▼ 8.42%AAPL$333.63▲ 4.27%MSFT$529.30▲ 5.92%GOOGL$347.68▲ 2.72%AMZN$256.29▼ 0.86%NVDA$239.24▲ 3.85%META$738.88▲ 19.80%TSLA$380.68▲ 7.51%BRK-B$505.54▼ 0.10%JPM$331.28▼ 7.63%V$370.64▼ 1.18%
RELIANCE₹1,218.00▼ 7.87%TCS₹2,100.00▼ 8.85%HDFCBANK₹711.45▼ 0.09%ICICIBANK₹1,342.80▼ 5.65%INFY₹1,013.85▼ 10.28%HINDUNILVR₹1,895.20▼ 3.96%ITC₹266.70▲ 0.98%SBIN₹958.75▼ 5.64%BHARTIARTL₹1,810.50▼ 1.60%KOTAKBANK₹431.90▲ 1.74%LT₹3,770.00▼ 4.90%AXISBANK₹1,248.00▼ 1.96%ASIANPAINT₹2,424.20▼ 4.08%MARUTI₹11,625.00▼ 8.42%AAPL$333.63▲ 4.27%MSFT$529.30▲ 5.92%GOOGL$347.68▲ 2.72%AMZN$256.29▼ 0.86%NVDA$239.24▲ 3.85%META$738.88▲ 19.80%TSLA$380.68▲ 7.51%BRK-B$505.54▼ 0.10%JPM$331.28▼ 7.63%V$370.64▼ 1.18%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← US stocks

🇺🇸ACH

Accendra Health, Inc. Common Stock

NYSE
$0.47
▼ $0.74 (-61.5%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 06 Oct 2026
H $4.69L $0.44-78.2%
$4.69$3.84$2.99$2.14$1.29$0.44$0.47
RSI (14)
Intraday · 15-minStrong sell-45RSI 39DowntrendMACD Bearishfor day-trading context — not advice

Technical signal

Neutral-5
RSI (14)17
oversold 30overbought 70
Trend
Downtrend
MACD
Bullish
Bollinger
Within bands
vs 20-day
below
vs 50-day
below
vs 200-day
below
Support
$0.44
Resistance
$1.15
  • Price is below its 50-day average (medium-term weakness).
  • RSI is 17 — oversold, a level some traders read as a potential entry zone.

Signal backtest · 2026-01-02 → 2026-10-06

Strategy return
-13.7%
Buy & hold
-79.7%
Trades
6
Win rate
17%

$100,000.00 invested would be worth $86,275.93 (-13.7%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Accendra Health, Inc.· Medical Distribution

source: yahoo

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Sector
Healthcare
Industry
Medical Distribution
Employees
6,500
Headquarters
Glen Allen, United States
www.accendrahealth.com ↗

Fundamentals

No fundamental data is currently available for this listing from our data providers.

Recent news

News sentiment:▲ Positive2↑ · 1↓ · 5–
  • New Strong Sell Stocks for October 6th▲ Positive
    Zacks · 06 Oct 2026
  • Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth▲ Positive
    Business Wire · 17 Sept 2026
  • Accendra Health drops equity issuance plan as CEO succession process advances▼ Negative
    InvestorsHub · 17 Aug 2026
  • Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans
  • MACD just crossed bullish (momentum turning up).
  • Educational technical indicators — not investment advice. TradeOrgs does not place trades.

    — Neutral
    Business Wire · 17 Aug 2026
  • UBS Adjusts Price Target on Acadia Healthcare to $1.50 From $4.50, Keeps Neutral Rating— Neutral
    MT Newswires · 14 Aug 2026
  • UBS Adjusts Price Target on Accendra Health to $1.50 From $4.50, Keeps Neutral Rating— Neutral
    MT Newswires · 13 Aug 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.